Progression of periodontal destruction and the roles of advanced glycation end products in experimental diabetes

Journal of Periodontology

Volumn 84, Issue 3, 2013, Pages 379-388

  Chang, Po Chun ^a,b,c   Chien, Li Ying ^a   Yeo, Jin Fei ^a   Wang, Yi Ping ^b   Chung, Min Chun ^a   Chong, Li Yen ^a   Kuo, Mark Yen Ping ^b,c   Chen, Chun Hao ^b,c   Chiang, Huan Ching ^b,c   Ng, Benjamin N ^a   Lee, Qi Qi ^a   Phay, Yong Kang ^a   Ng, Jeffery R ^a   Erk, Kok Yong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Advanced glycosylation end product receptor; Diabetes mellitus; Immunohistochemistry; Inflammation; Periodontitis; X ray microtomography

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; COLLAGEN; CYCLINE; IMMUNOGLOBULIN RECEPTOR; ISOENZYME; LIPOPOLYSACCHARIDE; TARTRATE-RESISTANT ACID PHOSPHATASE;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BIOSYNTHESIS; DISEASE COURSE; EXPERIMENTAL DIABETES MELLITUS; MALE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PERIODONTITIS; PHYSIOLOGY; PORPHYROMONAS GINGIVALIS; RADIOGRAPHY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ACID PHOSPHATASE; ALVEOLAR BONE LOSS; ANIMALS; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; GLYCOSYLATION END PRODUCTS, ADVANCED; ISOENZYMES; LIPOPOLYSACCHARIDES; MALE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; X-RAY MICROTOMOGRAPHY;

EID: 84874585214     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120076     Document Type: Article

References (44)

1. Saito T, Murakami M, Shimazaki Y, Matsumoto S, Yamashita Y. The extent of alveolar bone loss is associated with impaired glucose tolerance in Japanese men. J Periodontol 2006;77: 392-397. (Pubitemid 44740662)
2. LimLP, Tay FB, SumCF, ThaiAC. Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. J Clin Periodontol 2007;34: 118-123.
3. Cramer C, Freisinger E, Jones RK, et al. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 2010;19: 1875-1884.
4. Desta T, Li J, Chino T, Graves DT. Altered fibroblast proliferation and apoptosis in diabetic gingival wounds. J Dent Res 2010;89: 609-614.
5. Mealey B; American Academy of Periodontology. Diabetes and periodontal diseases. Committee on Research, Science and Therapy. J Periodontol 2000;71: 664-678.
6. Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: Mechanisms and insights into therapeutic modalities. Ann Periodontol 2001;6: 113-118.
7. Hudson BI, Bucciarelli LG, Wendt T, et al. Blockade of receptor for advanced glycation endproducts: A new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch Biochem Biophys 2003;419: 80-88. (Pubitemid 37272161)
8. Cerami C, Founds H, Nicholl I, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 1997;94: 13915-13920. (Pubitemid 28009684)
9. Anderson MM, Requena JR, Crowley JR, Thorpe SR, Heinecke JW. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl) lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 1999;104: 103-113. (Pubitemid 29534350)
10. Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez FM, Caudle RM, Heft MW. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: A study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol 2005;32: 40-44. (Pubitemid 40187424)
11. Retzepi M, Donos N. The effect of diabetes mellitus on osseous healing. Clin Oral Implants Res 2010;21: 673-681.
12. Blakytny R, Spraul M, Jude EB. Review: The diabetic bone: A cellular and molecular perspective. Int J Low Extrem Wounds 2011;10: 16-32.
13. Tesseromatis C, Kotsiou A, Parara H, Vairaktaris E, Tsamouri M. Morphological changes of gingiva in streptozotocin diabetic rats. Int J Dent 2009:725628.
14. Silva JA, Lorencini M, Reis JR, Carvalho HF, Cagnon VH, Stach-Machado DR. The influence of type I diabetes mellitus in periodontal disease induced changes of the gingival epithelium and connective tissue. Tissue Cell 2008;40: 283-292.
15. Kuhr A, Popa-Wagner A, Schmoll H, Schwahn C, Kocher T. Observations on experimental marginal periodontitis in rats. J Periodontal Res 2004;39: 101-106. (Pubitemid 39090090)
16. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: An epidemiologic perspective. Ann Periodontol 2001;6: 99-112.
17. Holzhausen M, Rossa Jú nior C, Marcantonio Jú nior E, Nassar PO, Spolidó rio DM, Spolidó rio LC. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. J Periodontol 2002;73: 1030-1036.
18. Nyman S, Schroeder HE, Lindhe J. Suppression of inflammation and bone resorption by indomethacin during experimental periodontitis in dogs. J Periodontol 1979;50: 450-461. (Pubitemid 10248095)
19. Crawford JM, Taubman MA, Smith DJ. The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with periodontopathic microorganisms. J Periodontal Res 1978;13: 316-325. (Pubitemid 8347660)
20. Hadjidakis DJ, Raptis AE, Sfakianakis M, Mylonakis A, Raptis SA. Bone mineral density of both genders in type 1 diabetes according to bone composition. J Diabetes Complications 2006;20: 302-307. (Pubitemid 44308584)
21. Soto N, Pruzzo R, Eyzaguirre F, et al. Bone mass and sex steroids in postmenarcheal adolescents and adult women with type 1 diabetes mellitus. J Diabetes Complications 2011;25: 19-24.
22. Bain S, Ramamurthy NS, Impeduglia T, Scolman S, Golub LM, Rubin C. Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone 1997; 21: 147-153. (Pubitemid 27395402)
23. de Almeida JM, Theodoro LH, Bosco AF, Nagata MJ, Bonfante S, Garcia VG. Treatment of experimental periodontal disease by photodynamic therapy in rats with diabetes. J Periodontol 2008;79: 2156-2165.
24. Sasaki T, Kaneko H, Ramamurthy NS, Golub LM. Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat Rec 1991;231: 25-34.
25. Chang PC, Chung MC, Wang YP, et al. Patterns of diabetic periodontal wound repair: A study utilizing micro-computed tomography and immunohistochemistry. J Periodontol 2012;83: 644-652.
26. Zambon JJ, Reynolds H, Fisher JG, Shlossman M, Dunford R, Genco RJ. Microbiological and immunological studies of adult periodontitis in patients with noninsulin-dependent diabetes mellitus. J Periodontol 1988;59: 23-31.
27. Ciantar M, Gilthorpe MS, Hurel SJ, Newman HN, Wilson M, Spratt DA. Capnocytophaga spp. in periodontitis patients manifesting diabetes mellitus. J Periodontol 2005;76: 194-203. (Pubitemid 40542246)
28. Pontes Andersen CC, Flyvbjerg A, Buschard K, Holmstrup P. Relationship between periodontitis and diabetes: Lessons from rodent studies. J Periodontol 2007;78: 1264-1275.
29. Iacopino AM. Periodontitis and diabetes interrelationships: Role of inflammation. Ann Periodontol 2001;6: 125-137.
30. Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: An overview. Ann Periodontol 2001;6: 91-98.
31. Chang KM, Ryan ME, Golub LM, Ramamurthy NS, McNamara TF. Local and systemic factors in periodontal disease increase matrix-degrading enzyme activities in rat gingiva: Effect of micocycline therapy. Res Commun Mol Pathol Pharmacol 1996;91: 303-318. (Pubitemid 26149051)
32. Jin P, Zhang X, Wu Y, et al. Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc 2010;42: 2745-2752.
33. Shires R, Teitelbaum SL, Bergfeld MA, Fallon MD, Slatopolsky E, Avioli LV. The effect of streptozotocininduced chronic diabetes mellitus on bone and mineral homeostasis in the rat. J Lab Clin Med 1981;97: 231-240. (Pubitemid 11136127)
34. Liu R, Bal HS, Desta T, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 2006;85: 510-514. (Pubitemid 43945487)
35. Hie M, Tsukamoto I. Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes. Int J Mol Med 2010;26: 611-618.
36. Basta G, Lazzerini G, Massaro M, et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: A mechanism for amplification of inflammatory responses. Circulation 2002;105: 816-822. (Pubitemid 34174921)
37. Mukherjee TK, Mukhopadhyay S, Hoidal Jr. The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta 2005;1744: 213-223. (Pubitemid 40798926)
38. Lin L. RAGE on the Toll road? Cell Mol Immunol 2006; 3: 351-358.
39. Janket SJ, Wightman A, Baird AE, Van Dyke TE, Jones JA. Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 2005;84: 1154-1159. (Pubitemid 43827784)
40. Takano M, Nishihara R, Sugano N, et al. The effect of systemic anti-tumor necrosis factor-alpha treatment on Porphyromonas gingivalis infection in type 2 diabetic mice. Arch Oral Biol 2010;55: 379-384.
41. Deo V, Gupta S, Bhongade ML, Jaiswal R. Evaluation of subantimicrobial dose doxycycline as an adjunct to scaling and root planing in chronic periodontitis patients with diabetes: A randomized, placebo-controlled clinical trial. J Contemp Dent Pract 2011;11: 009-016.
42. Engebretson SP, Hey-Hadavi J. Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: A pilot study. Pharmacol Res 2011;64: 624-629.
43. Di Paola R, Marzocco S, Mazzon E, et al. Effect of aminoguanidine in ligature-induced periodontitis in rats. J Dent Res 2004;83: 343-348. (Pubitemid 41713773)
44. Lalla E, Lamster IB, Feit M, et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 2000;105: 1117-1124. (Pubitemid 30217696)